🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Anesthesia and Non-small Cell Lung Cancer Recurrence

RecruitingPhase 4Ages 19 Years - anyAllSamsung Medical Center
NCT06330038 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

There has been ongoing debate about the relationship between cancer recurrence and anesthetic management. Therefore, the investigators will test the hypothesis that the recurrence free survival (RFS) after curative resection of NSCLC is higher in patient who received total intravenous anesthesia (TIVA) than volatile anesthetics in this multi-center randomized trials.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * American Society of Anesthesiologists physical status (ASA) Ⅰ-Ⅲ * The Eastern Cooperative Oncology Group (ECOG) performance status 0-2 * Lung resection surgery (segmentectomy, lobectomy, bilobectomy, pneumonectomy; video-assisted, robot-assisted, or open) with curative intent for NSCLC (clinical Tumor, Node, Metastasis (TNM) stage Ⅰ- ⅢA). Exclusion Criteria: * Distant metastasis or malignant tumor in other organs that according to the attending surgeon is not in long-term remission * Severe neurologic conditions * Severe hepatic disease (Child-Pugh classification C) * Renal failure requiring renal replacement therapy * History of anesthesia and/or surgery within 1 yr * Previous surgery due to lung cancer (except diagnostic biopsies) * Contraindications to any study medication (history of allergy, hypersensitivity reaction, or any other contraindication) * Planned joint extrapulmonary procedure * Surgery under cardiopulmonary bypass or extracorporeal membrane oxygenation * Postoperative sedation * Pregnancy, or lactation * Patient refusal.
💊

What it tests

  • Propofol
  • Inhaled anesthetics
📍

Where

1 site
Samsung Medical Center
Seoul, South Korea
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy